Serum IL-13 and IL-31 Levels are not Attenuated upon Dupilumab Treatment: Lessons from a Prospective Cohort

Ghazal Suleiman1, Ilanit Boyango2, Marwan Dawood3

  • 1The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Laboratory of Skin Cancer Research, Clinical Research Institute (CRIR), Rambam Health Care Campus, Haifa, Israel; Department of Dermatology, Rambam Health Care Campus, Haifa, Israel.

Abstract

No abstract available in PubMed .

Related Concept Videos